Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alnylam says it won Europe RNA patent dispute
Yahoo/AP
Friday, December 3, 2010 - 6:44am
tags:
patents, Alnylam, RNA, gene silencing, Merck, Pfizer, Sima
AstraZeneca: FDA panel says vandetanib could help some medullary thyroid cancer patients
Yahoo/AP
Thursday, December 2, 2010 - 6:59pm
tags:
FDA, AstraZeneca, vandetanib, thyroid cancer
Roche CEO sees generic co's, innovators as winners
Reuters, UK
Thursday, December 2, 2010 - 4:50pm
tags:
Roche, generics, innovation, Severin Schwan, Pharma CEOs
Is Seattle Genetics the Next Big Thing?
Minyanville
Thursday, December 2, 2010 - 4:47pm
tags:
Seattle Genetics, brentuximab vedotin, lymphoma
Sequenom Falls on Stock Sale
Barron's
Thursday, December 2, 2010 - 4:45pm
tags:
Sequenom, stock offering
GE teams up with J&J on hunt for early Alzheimer's biomarkers
Fierce Biotech
Thursday, December 2, 2010 - 1:00pm
tags:
GE, JNJ, Alzheimer's disease, biomarkers
Cubist says FDA approves fast-injection Cubicin
Yahoo/AP
Thursday, December 2, 2010 - 12:59pm
tags:
FDA, Cubist Pharmaceuticals, Cubicin, antibiotics
Ex-Glaxo lawyer pleads not guilty to obstruction
Reuters
Thursday, December 2, 2010 - 12:15pm
tags:
GSK, antidepressants
Momenta files generic Lovenox lawsuit against Teva
Yahoo/AP
Thursday, December 2, 2010 - 12:14pm
tags:
Momenta, Teva Pharmaceuticals, generics, Lovenox, lawsuits, Novartis, Sanofi
Are Death Panels For Overpriced Cancer Drugs Coming To The FDA?
Forbes
Thursday, December 2, 2010 - 12:12pm
tags:
cancer, FDA, advisory panels, Roche, Avastin
Regulatory experts see huge challenges on biosimilar rules
Fierce Biotech
Thursday, December 2, 2010 - 10:20am
tags:
biosimilars, FDA, Europe
Orexigen Options Suggest Contrave Diet Pill May Avoid Arena, Vivus Delays
Bloomberg
Thursday, December 2, 2010 - 10:17am
tags:
Orexigen, options, Contrave, obesity, Vivus, Arena Pharmaceuticals
Glaxo Nears Deal to Buy Chinese Drug Firm
WSJ Online
Thursday, December 2, 2010 - 9:39am
tags:
Nanjing MeiRui, M&A, GSK, China
Aveo's Coming Out Party
Minyanville
Thursday, December 2, 2010 - 9:38am
tags:
Aveo Pharmaceutical, Astellas, OSI Pharmaceuticals
Ariad Sees Options Interest Boost
Seeking Alpha
Thursday, December 2, 2010 - 9:36am
tags:
Ariad Pharmaceuticals, options, ridaforolimus
Merck & Co. buying SmartCells for $500 million
Marketwatch
Thursday, December 2, 2010 - 9:20am
tags:
SmartCells, M&A, Merck, diabetes
Will Johnson & Johnson Get a Consent Decree?
Seeking Alpha
Thursday, December 2, 2010 - 9:18am
tags:
JNJ, recalls, consent decree
DOJ Shows Concern Over Pending Off-Label Speech Case
Forbes
Wednesday, December 1, 2010 - 9:05pm
tags:
DOJ, off-label, Xyrem, Jazz Pharmaceuticals
J&J Recall Watch: This Time, it’s Mylanta (and Contact Lenses)
WSJ Online
Wednesday, December 1, 2010 - 9:03pm
tags:
Mylanta, contact lens, JNJ, recalls
Glaxo Fails to Win Panel’s Vote for Wider Avodart Use
Bloomberg
Wednesday, December 1, 2010 - 9:02pm
tags:
GSK, Avodart, advisory panels, prostate cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.